Adjunct Professor Stephen Cornelissen talks about how Mercy Health is expanding its services to support more people across the country.
Executive Interview Categories: Healthcare & Pharmaceutical
Mark Fladrich is the MD of AstraZeneca Australia, a company that produces new treatments and medicines to improve the lives of everyday individuals.
Soho Flordis International produces natural medicines. Nigel Pollard credits the company’s success to the growing scepticism of synthetic chemicals.
Monash Health builds on 160 years of delivering quality care. Shelly Park remains focussed on innovation and research, strong values and strategic vision.
Bo Nilsson believes Nets’ core strength lies in its ability to bring complex and innovative products and services to its strong customer base.
Dr George J Syrmalis, CEO and founder of The iQ Group, is passionate about drug discovery and the future of medicine.
Guided by CEO Olav Thorstad, Health & Fitness Nordic is continually launching new products and technologies to cater to its entire spectrum of clients.
Dr Jacques de Toeuf explains that CHIREC is investing in a new hospital and the latest technology to provide its patients with the best treatment…
Guided by Eva Steiness, Serodus is mediating between academic and commercial entities to develop products for the treatment of cardiovascular diseases.
To deliver better health services, Director General of Queensland Health Ian Maynard is facilitating a cultural shift towards greater innovation.
Anne Cross talks about bringing UnitingCare Queensland’s person-centred health and community services to its new digital hospital.
CEO Jennifer Williams shares how The Australian Red Cross Blood Service is investing in leading-edge research to improve its business efficiency.
